23P Combination chemotherapy and hormone therapy (CHT) in patients with hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC): A single-centre retrospective analysis

Autor: Bajaj, K., Vora, D.N., Parab, P., Shaikh, H., Gulia, S., Rath, S., Bajpai, J., Shet, T., Desai, S., Popat, P., Rajan, R., Nair, N.S., Joshi, S., Pathak, R., Sarin, R., Kembhavi, Y., Rane, S., Ghosh, J., Badwe, R.A., Gupta, S.
Zdroj: In Annals of Oncology November 2022 33 Supplement 9:S1439-S1439
Databáze: ScienceDirect